FR2962436B1 - Derives de xanthedediones pour le traitement des troubles de la pigmentation et du vieillissement cutane - Google Patents

Derives de xanthedediones pour le traitement des troubles de la pigmentation et du vieillissement cutane

Info

Publication number: FR2962436B1
Authority: FR; France
Prior art keywords: xanthedediones; pigmentation; derivatives; treatment; skin aging
Prior art date: 2010-07-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR1055595A

Other languages

English (en)

Other versions

FR2962436A1 (fr

Inventor

Stephane Poigny

Francoise Belaubre

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pierre Fabre Dermo Cosmetique SA

Original Assignee

Pierre Fabre Dermo Cosmetique SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-07-09

Filing date

2010-07-09

Publication date

2012-12-14

2010-07-09 Priority to FR1055595A priority Critical patent/FR2962436B1/fr

2010-07-09 Application filed by Pierre Fabre Dermo Cosmetique SA filed Critical Pierre Fabre Dermo Cosmetique SA

2011-07-08 Priority to AU2011275686A priority patent/AU2011275686B2/en

2011-07-08 Priority to SG2013000872A priority patent/SG186941A1/en

2011-07-08 Priority to KR1020137003123A priority patent/KR20130043181A/ko

2011-07-08 Priority to JP2013517403A priority patent/JP5829272B2/ja

2011-07-08 Priority to ARP110102461A priority patent/AR082141A1/es

2011-07-08 Priority to RU2013103030/04A priority patent/RU2598374C2/ru

2011-07-08 Priority to NZ605750A priority patent/NZ605750A/en

2011-07-08 Priority to TW100124230A priority patent/TWI538693B/zh

2011-07-08 Priority to EP11730320.6A priority patent/EP2590959A1/fr

2011-07-08 Priority to BR112013000431A priority patent/BR112013000431A2/pt

2011-07-08 Priority to PCT/EP2011/061637 priority patent/WO2012004390A1/fr

2011-07-08 Priority to CN201180034125.0A priority patent/CN102985415B/zh

2011-07-08 Priority to MA35578A priority patent/MA34390B1/fr

2011-07-08 Priority to PH1/2013/500026A priority patent/PH12013500026A1/en

2011-07-08 Priority to MX2013000077A priority patent/MX2013000077A/es

2011-07-08 Priority to US13/808,456 priority patent/US8906416B2/en

2011-07-08 Priority to CA2804334A priority patent/CA2804334A1/fr

2012-01-13 Publication of FR2962436A1 publication Critical patent/FR2962436A1/fr

2012-12-14 Application granted granted Critical

2012-12-14 Publication of FR2962436B1 publication Critical patent/FR2962436B1/fr

2013-01-06 Priority to IL224123A priority patent/IL224123A/en

2013-01-16 Priority to ZA2013/00413A priority patent/ZA201300413B/en

2013-05-06 Priority to HK13105388.4A priority patent/HK1178521A1/xx

Status Expired - Fee Related legal-status Critical Current

2030-07-09 Anticipated expiration legal-status Critical

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/08—Preparations for bleaching the hair
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Birds (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Gerontology & Geriatric Medicine (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Rheumatology (AREA)
Toxicology (AREA)
Pain & Pain Management (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyrane Compounds (AREA)
Saccharide Compounds (AREA)

FR1055595A 2010-07-09 2010-07-09 Derives de xanthedediones pour le traitement des troubles de la pigmentation et du vieillissement cutane Expired - Fee Related FR2962436B1 (fr)

Priority Applications (21)

Application Number	Priority Date	Filing Date	Title
FR1055595A FR2962436B1 (fr)	2010-07-09	2010-07-09	Derives de xanthedediones pour le traitement des troubles de la pigmentation et du vieillissement cutane
MA35578A MA34390B1 (fr)	2010-07-09	2011-07-08	Dérivés de xanthènedione pour le traitement de troubles de pigmentation et de vieillissement de la peau
KR1020137003123A KR20130043181A (ko)	2010-07-09	2011-07-08	색소침착 및 피부노화 질환 치료용 잔텐디온 유도체
JP2013517403A JP5829272B2 (ja)	2010-07-09	2011-07-08	色素沈着および皮膚老化障害の治療のためのキサンテンジオン誘導体
ARP110102461A AR082141A1 (es)	2010-07-09	2011-07-08	Derivados xantenodiona para el tratamiento de trastornos de pigmentacion y de envejecimiento de la piel
RU2013103030/04A RU2598374C2 (ru)	2010-07-09	2011-07-08	Производные ксантендиона для лечения пигментации и старения кожи
NZ605750A NZ605750A (en)	2010-07-09	2011-07-08	Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders
TW100124230A TWI538693B (zh)	2010-07-09	2011-07-08	用於治療色素沉著與皮膚老化病症之二苯并哌喃二酮衍生物
EP11730320.6A EP2590959A1 (fr)	2010-07-09	2011-07-08	Dérivés de xanthènedione pour le traitement de troubles de pigmentation et de vieillissement de la peau
SG2013000872A SG186941A1 (en)	2010-07-09	2011-07-08	Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders
AU2011275686A AU2011275686B2 (en)	2010-07-09	2011-07-08	Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders
CN201180034125.0A CN102985415B (zh)	2010-07-09	2011-07-08	用于治疗色素沉着和皮肤衰老疾病的呫吨二酮衍生物
MX2013000077A MX2013000077A (es)	2010-07-09	2011-07-08	Derivados de xantendiona para el tratamiento de los desordenes de pigmentacion y envejecimiento de la piel.
PCT/EP2011/061637 WO2012004390A1 (fr)	2010-07-09	2011-07-08	Dérivés de xanthènedione pour le traitement de troubles de pigmentation et de vieillissement de la peau
PH1/2013/500026A PH12013500026A1 (en)	2010-07-09	2011-07-08	Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders
US13/808,456 US8906416B2 (en)	2010-07-09	2011-07-08	Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders
CA2804334A CA2804334A1 (fr)	2010-07-09	2011-07-08	Derives de xanthenedione pour le traitement de troubles de pigmentation et de vieillissement de la peau
BR112013000431A BR112013000431A2 (pt)	2010-07-09	2011-07-08	derivados de xantenodiona para o tratamento de distúrbios de pigmentação e envelhecimento de pele
IL224123A IL224123A (en)	2010-07-09	2013-01-06	Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders
ZA2013/00413A ZA201300413B (en)	2010-07-09	2013-01-16	Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders
HK13105388.4A HK1178521A1 (en)	2010-07-09	2013-05-06	Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR1055595A FR2962436B1 (fr)	2010-07-09	2010-07-09	Derives de xanthedediones pour le traitement des troubles de la pigmentation et du vieillissement cutane

Publications (2)

Publication Number	Publication Date
FR2962436A1 FR2962436A1 (fr)	2012-01-13
FR2962436B1 true FR2962436B1 (fr)	2012-12-14

Family

ID=43759812

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR1055595A Expired - Fee Related FR2962436B1 (fr)	2010-07-09	2010-07-09	Derives de xanthedediones pour le traitement des troubles de la pigmentation et du vieillissement cutane

Country Status (21)

Country	Link
US (1)	US8906416B2 (fr)
EP (1)	EP2590959A1 (fr)
JP (1)	JP5829272B2 (fr)
KR (1)	KR20130043181A (fr)
CN (1)	CN102985415B (fr)
AR (1)	AR082141A1 (fr)
AU (1)	AU2011275686B2 (fr)
BR (1)	BR112013000431A2 (fr)
CA (1)	CA2804334A1 (fr)
FR (1)	FR2962436B1 (fr)
HK (1)	HK1178521A1 (fr)
IL (1)	IL224123A (fr)
MA (1)	MA34390B1 (fr)
MX (1)	MX2013000077A (fr)
NZ (1)	NZ605750A (fr)
PH (1)	PH12013500026A1 (fr)
RU (1)	RU2598374C2 (fr)
SG (1)	SG186941A1 (fr)
TW (1)	TWI538693B (fr)
WO (1)	WO2012004390A1 (fr)
ZA (1)	ZA201300413B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW201444827A (zh) *	2013-03-12	2014-12-01	Daiichi Sankyo Co Ltd	苯基□衍生物
US12134623B1 (en)	2023-10-17	2024-11-05	King Faisal University	2,16-dioxapentacyclo[7.7.5.01,21.03,8.010,15]henicosa3(8),10,12,14-tetraene-7,20-dione as an antimicrobial compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU895985A1 (ru) *	1980-03-27	1982-01-07	Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср	9-Ароил-3,3,6,6-тетраметил-1,2,3,4,5,6,7,8-октагидроксантен-1,8-дионы в качестве промежуточных продуктов дл синтеза соединений,обладающих антиоксидантной активностью
JP3498857B2 (ja) *	1994-01-28	2004-02-23	株式会社ノエビア	皮膚外用剤
GB9707695D0 (en) *	1996-08-07	1997-06-04	Hoffmann La Roche	Tricyclic dione derivatives
US7390668B2 (en) *	1996-10-30	2008-06-24	Provectus Pharmatech, Inc.	Intracorporeal medicaments for photodynamic treatment of disease
FR2756183B1 (fr) *	1996-11-25	1999-08-27	Fabre Pierre Dermo Cosmetique	Association d'huile et de peptides d'argan utile pour le traitement des troubles lies au vieillissement cutane
ES2310521T3 (es) *	1999-08-13	2009-01-16	Provectus Pharmatech, Inc.	Medicamentos topicos mejorados y metodos que permiten el tratamiento de enfermedades de manera fotodinamica.
EP1213025A1 (fr)	2000-12-06	2002-06-12	Laboratoires Serobiologiques(Societe Anonyme)	Composition cosmétique et/ou dermopharmaceutique conténant un extrait obtenu à partir de feuilles d'Argania spinosa
GB0215534D0 (en) *	2002-07-04	2002-08-14	Ecole Polytech	Selective photochemotherapy using oligonucleotide targeting agents
US20060105069A1 (en) *	2004-11-16	2006-05-18	Alex Moffett	Pharmaceutical and therapeutic compositions derived from Garcinia mangostana L plant

2010
- 2010-07-09 FR FR1055595A patent/FR2962436B1/fr not_active Expired - Fee Related
2011
- 2011-07-08 PH PH1/2013/500026A patent/PH12013500026A1/en unknown
- 2011-07-08 EP EP11730320.6A patent/EP2590959A1/fr not_active Withdrawn
- 2011-07-08 JP JP2013517403A patent/JP5829272B2/ja not_active Expired - Fee Related
- 2011-07-08 AU AU2011275686A patent/AU2011275686B2/en not_active Ceased
- 2011-07-08 KR KR1020137003123A patent/KR20130043181A/ko not_active Application Discontinuation
- 2011-07-08 MX MX2013000077A patent/MX2013000077A/es active IP Right Grant
- 2011-07-08 SG SG2013000872A patent/SG186941A1/en unknown
- 2011-07-08 NZ NZ605750A patent/NZ605750A/en not_active IP Right Cessation
- 2011-07-08 CA CA2804334A patent/CA2804334A1/fr not_active Abandoned
- 2011-07-08 BR BR112013000431A patent/BR112013000431A2/pt not_active IP Right Cessation
- 2011-07-08 AR ARP110102461A patent/AR082141A1/es unknown
- 2011-07-08 CN CN201180034125.0A patent/CN102985415B/zh not_active Expired - Fee Related
- 2011-07-08 US US13/808,456 patent/US8906416B2/en not_active Expired - Fee Related
- 2011-07-08 TW TW100124230A patent/TWI538693B/zh not_active IP Right Cessation
- 2011-07-08 MA MA35578A patent/MA34390B1/fr unknown
- 2011-07-08 RU RU2013103030/04A patent/RU2598374C2/ru not_active IP Right Cessation
- 2011-07-08 WO PCT/EP2011/061637 patent/WO2012004390A1/fr active Application Filing
2013
- 2013-01-06 IL IL224123A patent/IL224123A/en active IP Right Grant
- 2013-01-16 ZA ZA2013/00413A patent/ZA201300413B/en unknown
- 2013-05-06 HK HK13105388.4A patent/HK1178521A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL224123A (en)	2016-06-30
US8906416B2 (en)	2014-12-09
RU2598374C2 (ru)	2016-09-27
FR2962436A1 (fr)	2012-01-13
MX2013000077A (es)	2013-03-18
ZA201300413B (en)	2013-09-25
CN102985415B (zh)	2015-07-01
AU2011275686A1 (en)	2013-01-31
MA34390B1 (fr)	2013-07-03
EP2590959A1 (fr)	2013-05-15
RU2013103030A (ru)	2014-08-20
JP2013530203A (ja)	2013-07-25
CN102985415A (zh)	2013-03-20
TWI538693B (zh)	2016-06-21
PH12013500026A1 (en)	2016-11-16
SG186941A1 (en)	2013-02-28
TW201206488A (en)	2012-02-16
BR112013000431A2 (pt)	2016-05-17
AU2011275686B2 (en)	2014-11-27
KR20130043181A (ko)	2013-04-29
WO2012004390A1 (fr)	2012-01-12
HK1178521A1 (en)	2013-09-13
US20130108568A1 (en)	2013-05-02
NZ605750A (en)	2015-12-24
AR082141A1 (es)	2012-11-14
CA2804334A1 (fr)	2012-01-12
JP5829272B2 (ja)	2015-12-09

Publication	Publication Date	Title
EP2709672A4 (fr)	2014-12-31	Compositions et méthodes pour le traitement de maladies de la rétine
EP2882445A4 (fr)	2016-06-15	Exosomes et acides micro-ribonucléiques pour la régénération de tissus
IL259547B (en)	2020-04-30	Isolated protein and preparations containing it for use in the treatment of disorders caused by il-1
HK1213192A1 (zh)	2016-06-30	用於在人類受試者中治療眼部疾病的方法和裝置
PL2704704T3 (pl)	2019-04-30	Bakterie probiotyczne do miejscowego leczenia zaburzeń skóry
EP2621499A4 (fr)	2014-04-09	Méthodes de traitement de maladies allergiques
EP2542060A4 (fr)	2013-08-14	Compositions et méthodes pour le traitement et/ou la prévention de maladies cardio-vasculaires
IL225239A0 (en)	2013-06-27	Compounds for the treatment of acne and related diseases
EP2877184A4 (fr)	2016-03-30	Compositions et traitement pour maladies et troubles oculaires
HK1198909A1 (en)	2015-06-19	Compositions and methods for the treatment of hepatic diseases and disorders
IL223286A0 (en)	2013-02-03	Piperidine derivatives and their use for the treatment of metabolic disorders
EP2623494A4 (fr)	2014-04-02	Agent pour le traitement de maladies oculaires
EP2906594A4 (fr)	2016-03-30	Méthodes et compositions pour le traitement de la sclérose en plaques et de troubles associés
HK1204573A1 (en)	2015-11-27	Treatment of inflammatory skin disorders
FR2992173B1 (fr)	2014-10-24	Procece cosmetique d'eclaircissement de la peau et/ou des levres
EP2922534A4 (fr)	2016-05-11	Méthodes et compositions pour le traitement de maladies neurodégénératives
EP2709632A4 (fr)	2015-03-04	Compositions et procédés pour le traitement de maladies de la peau
EP2825173A4 (fr)	2015-12-09	Inhibiteurs de calmoduline pour le traitement de troubles ribosomiques et de ribosomapathies
EP2575841A4 (fr)	2013-10-30	Extraits de peau de pomme utilisés pour le traitement des maladies cardiovasculaires
EP2887947A4 (fr)	2016-01-06	Traitement de la drépanocytose et de troubles inflammatoires
EP2903643A4 (fr)	2016-06-15	Traitement d'affections psychiatriques
EP2838521A4 (fr)	2015-03-11	Formulations et procédés pour le traitement de plaies et d'affections cutanées inflammatoires
EP2723325A4 (fr)	2015-03-11	Nouvelles formulations et méthodes de traitement de troubles ou de maladies dermatologiques
GB201114289D0 (en)	2011-10-05	Flurbiprofen and related compounds for the treatment of skin diseases
HK1158954A1 (en)	2012-07-27	1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases

Legal Events

Date	Code	Title	Description
2016-07-29	PLFP	Fee payment	Year of fee payment: 7
2018-04-27	ST	Notification of lapse	Effective date: 20180330